APRIL 26, 2021


Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing.

The financing included:


  • $9m debt financing from SVB, and
  • $12m equity investment led by Savitr Capital and other private investors.

The company intends to use the funds to invest in research and development around patient safety, provider workflows and analytics, add talent to its workforce and enhance integrations with EHRs, mobile apps and other diabetes technology across the continuum of care.

Led by Ed Furlong, President and Chief Executive Officer, Glytec is an insulin management software company that delivers personalized diabetes treatment recommendations across the continuum of care, from hospital to home. eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized insulin dosing regimens, and get patients into target blood glucose range quickly.

More than 300 hospitals across the United States, at health systems including AdventHealth, Novant Health and Sentara Healthcare, use Glytec to support inpatient insulin dosing and glycemic management.

– This article originally appeared on FinSMEs. 

ECO #01116-A